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Background: Turner syndrome is caused by numeric and structural abnormalities of the X chromosome. An
increased frequency of autoimmunity as well as an elevated incidence of autoantibodies was observed in Turner
patients. The aim of this study was to conduct a retrospective analysis of the incidence of autoimmunity in 66
Italian patients affected by Turner syndrome.
Methods: Sixty-six unselected and consecutive Italian Turner patients were recruited. The association between age,
karyotype and the presence of clinical/pre-clinical autoimmune disorders and of autoantibodies was examined.
Results: Out of the 66 Turner patients, 26 had thyroid autoimmune disorders (39.4%), 14 patients had Hashimoto’s
thyroiditis with clinical or subclinical hypothyroidism (21.2%) and 12 patients had circulating anti-thyroid antibodies,
echographic pattern of diffuse hypoechogenicity and normal thyroid hormone levels (18.2%). None were affected
by Graves’ disease. We analyzed the overall incidence of thyroid autoimmunity within the 3 different age groups
0–9.9, 10–19.9 and 20–29.9 years. No statistically significant difference was observed in the incidence of thyroid
autoimmunity within the age-groups (χ2-test p > 0.05).
Out of the 66 patients, 31 patients had the 45,X karyotype; within this first group 14 out of 31 patients were
affected by autoimmune thyroid disease. A second group of 29 patients included 19 patients with mosaicism,
5 patients with deletions and 5 patients with ring chromosome; out of these 29 patients 7 were affected by
autoimmune thyroid disease. A third group included 6 patients with X isochromosome; 5 out of 6 were affected by
autoimmune thyroid disease. A statistically significant difference in the frequency of thyroid autoimmunity within
the different karyotype groups was observed (χ2-test p = 0.0173).
When comparing the X isochromosome group with the pooled group of other karyotypes, of note, the frequency
of thyroid autoimmunity was statistically higher in the X isochromosome group (Fisher exact test p = 0.0315).
Conclusions: Our data confirm a high frequency of thyroid autoimmunity in Italian Turner patients. Patients with X
isochromosome are more prone to develop thyroid autoimmunity. Further, an early assay of autoantibodies and
monitoring thyroid hormones is fundamental for detecting hypothyroidism earlier and start adequate replacement
therapy.
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Turner syndrome (TS) is a condition caused by numeric
and/or structural abnormalities of the X chromosome
[1]. Short stature and gonadal dysgenesis are the most
frequent clinical features [2]. With a prevalence of 1:2,500
to 1:3,000 among live-born girls [3,4] and a 45, X karyo-
type found in approximately 10% of spontaneous aborp-
tions (reviewed in [2,5]), TS is one of the most common* Correspondence: alessandra.fierabracci@opbg.net
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stated.chromosomal abnormality. Several studies report an in-
creased frequency of autoimmunity in TS patients [3,6,7]
possibly due to a complex interplay of genetic and en-
vironmental factors [6,8]. Haploinsufficiency of genes on
the X chromosome could be responsible for lack of self-
protein exposure in the thymus and escape of autoreactive
T cells, thus predisposing to autoimmunity [6]. It has even
been hypothesized that, since autoimmune disorders are
frequent in relatives of families of TS patients, abnormal
gametogenesis and non-dysjunctional events are due to
abnormal autoimmune responsiveness [1,2,6].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Hashimoto’s thyroiditis has been estimated to affect
around 50% of TS patients [2,9]. Other most commonly
associated autoimmune disorders are: celiac disease (CD)
[3,4], ulcerative colitis, Crohn’s disease, psoriasis, idio-
pathic thrombocytopenic purpura, vitiligo and juvenile
rheumatoid arthritis [6]. In a recent investigation by
Bakalov et al. [10], findings show that lymphocytic thy-
roiditis increases greatly in both, women with TS and
women with karyotypically normal primary ovarian insuf-
ficiency (POI), suggesting that factors associated with
ovarian insufficiency per se are responsible for this auto-
immune condition. In addition the absence of a normal
second X chromosome may contribute to increase the risk
of autoimmunity in TS patients.
Thyroid autoimmune diseases are characterized by
abnormal lymphocytic activation, directed against self-
antigens, i.e. thyroglobulin (Tg) and thyroperoxidase
(TPO) [11]. They encompasses Hashimoto’s thyroiditis
(HT), a predominantly T cell mediated disease and
Graves’ disease, characterized by a primarily humoral re-
sponse and the presence of anti-thyroid stimulating hor-
mone (TSH) receptor antibodies [11].
Although a higher prevalence of Hashimoto’s thy-
roiditis in TS patients was found in several studies, dif-
ferent percentages for the presence of circulating thyroid
autoantibodies (Abs) and clinical diseases occur in vari-
ous cohorts of patients investigated [12-15]. Moreover,
in thyroid autoimmune disorders, a low prevalence of
Graves’ disease was reported [12,16,17].
Interestingly, regarding the putative influence of kar-
yotype on clinical features, some studies reported an as-
sociation between autoimmune thyroiditis and the X
isochromosome karyotype [12,17-21]; however, the small
number of patients investigated limits its significance.
This hypothesis was formulated on the basis that X iso-
chromosome abnormality is more frequent in Hashimo-
to’s thyroiditis [12].
Contrary to studies that confirm a prevalent associ-
ation between TS and thyroid autoimmunity, data from
a Danish TS registry shows that when compared to
Danish women in general, TS subjects had a 4-fold
increased risk of developing male-predominant auto-
immune diseases such as insulin dependent diabetes
mellitus (Type 1 diabetes, T1D) [7]. Amyotrophic lateral
sclerosis, ankylosing spondylitis, reactive arthritis and
Dupuytren’s contracture are other male-predominant
autoimmune diseases that could affect TS patients. This
phenomenon indicates that while there is compensation
by the normally functioning copy on the other X chromo-
some in women with a normal karyotype, a harmful allele
will occur in TS females and males due to X monosomy
[7]. To complete the spectrum of autoimmune abnorma-
lities in TS, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) was also re-
ported in a patient with premature ovarian failure (POF)
and primary amenorrhea [22].
We conducted a retrospective analysis on the inci-
dence of autoimmune manifestations in 66 Italian unse-
lected and consecutive TS patients, recruited from the
Bambino Gesù Children’s Hospital in Rome. The results
were related to the age of the patients and their karyo-
type and will be discussed by comparing them with
those reported in other studies.
Methods
Subjects
Sixty-six TS patients, aged 1–29.8 years, were recruited
from the Bambino Gesù Children’s Hospital in Rome.
All patients underwent chromosome analysis, which
showed the presence of these karyotypes: 45,X (n = 31,
47%); mosaic (n = 19, 28.8%), with deletions (n = 5, 7.6%)
and ring chromosomes (n = 5, 7.6%), and with isochro-
mosomes (n = 6, 9.1%). Among the 31 patients with kar-
yotype 45,X, SRY material was detected by FISH analysis
in 2 patients. For one patient, as already reported in an-
other study [1], standard karyotype analysis showed mo-
saicism for X monosomy and a complex rearrangement
involving chromosome 2 and chromosome 10 (partial
monosomy 2q and trisomy 10p). Karyotype was inter-
preted according to the International System for Human
Cytogenetic Nomenclature (ISCN 2013).
Thyroid function was assessed in all patients at first
presentation and at every follow-up visit. The defin-
ition of subclinical hypothyroidism was based on TSH
levels >5.5 to 10 mcUI/ml [23] with normal FT3 (free
triiodothyronine) and FT4 (free thyroxine) levels. The
diagnosis of overt hypothyroidism was made when TSH
values were higher than 5mcUI/ml and FT3 (free triiodo-
thyronine) and FT4 (free thyroxine) levels were below the
normal range. During the clinical follow-up patients exhi-
biting subclinical/overt hypothyroidism or with positive
TPO and/or Tg antibodies underwent thyroid ultrasound.
Diffuse low echogenicity was considered an indicator of
thyroid autoimmune disease [24].
Ethical issues
Informed consent was obtained from all TS patients or
their parents if they were younger than 18 years. The in-
vestigation was approved by the Ethics Committee of
the Hospital.
Detection of autoantibodies
Sera of each patient were assessed for autoantibodies
in parallel to thyroid function at first presentation
and at every follow-up visit. Patients’ sera were tested
for Abs to Tg and TPO by chemiluminescence method;
parietal cells, adrenal cortex and islet cell by indirect
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glutamic acid decarboxylase (isoform 65) (GADA), protein
tyrosine phosphatase IA2 (insulinoma-associated anti-
gen 2) and insulin by RIA. Total IgA, IgA anti-gliadin
and anti-transglutaminase were also measured for celiac
screening [25].Statistical analysis
Qualitative variables were described as numbers and
percentages. A χ2-test was used to compare frequency
of qualitative variables among the different groups. A
Fisher’s exact test was computed for 2x2 tables. Results
were analyzed using the GraphPad Prism software ver-
sion number 5 (San Diego, California, USA). A result with
p < 0.05 was considered statistically significant.Results
Autoimmune manifestations in TS patients
Autoimmune thyroid disease (ATD) was the most com-
mon autoimmune disorder.
Out of the 66 TS patients, 26 had thyroid autoimmune
disorders (39.4%) (Table 1), 14 patients had Hashimoto’s
thyroiditis with clinical or subclinical hypothyroidism
(21.2%) and 12 patients had circulating anti-thyroid Abs,
echographic pattern of diffuse hypoechogenicity and nor-
mal thyroid hormone levels (18.2%). None were affected
by Graves’ disease. In addition, one patient had already
reported [1] that she developed celiac disease at the age
of 3.5 years and was also affected by clinical T1D,
Hashimoto’s thyroiditis and alopecia universalis. One
patient had circulating Abs against antigens related to
T1D but no clinical manifestations of overt disease.
One patient, at the age of 9.3 years, had developed
anti-transglutaminase Abs that indicate CD and ano-
ther patient was affected by vitiligo associated with
thyroid autoimmunity.
Since thyroid autoimmunity was the most frequent
autoimmune disorder, we analyzed the overall incidence
of thyroid autoimmunity within the 3 different age
groups 0–9.9, 10–19.9 and 20–29.9 years. As shown in
Table 1, no statistically significant difference was ob-
served in the incidence of thyroid autoimmunity within
the age-groups (χ2-test = p > 0.05).Table 1 TS patients with thyroid autoimmunity across
age-groups




0–9.9 years 12 16.7% (n = 2)
10–19.9 years 38 47.4% (n = 18)
20–29.9 years 16 37.5% (n = 6)
No statically significant difference in the incidence of thyroid autoimmunity
was observed in the age groups.Table 2 illustrates the number of TS patients with thy-
roid autoimmunity within the different karyotype groups.
Out of the total group of 66 patients, 31 patients had the
45, X karyotype; within this first group 14 out of 31 pa-
tients were affected by ATD (45.2%; 21.2% of the total
group of patients). A second group of 29 patients included
19 patients with mosaicism, 5 patients with deletions and
5 patients with ring chromosome; out of these 29 patients
7 were affected by ATD (24.1%; 10.6% of the total group
of 66 patients). A third group included 6 patients with X
isochromosome; 5 out of 6 were affected by ATD (83.3%;
7.6% of the total group of 66 patients) (Table 2). As shown
in Table 2, there was a statistically significant difference in
the frequency of thyroid autoimmunity within the diffe-
rent karyotype groups (χ2-test p = 0.0173).
Nevertheless, although the analysis is limited by the
small number of TS patients with X isochromosome,
when comparing this group with the pooled group of
other karyotypes, of note, the frequency of thyroid auto-
immunity was statistically higher in the X isochromo-
some group (Fisher exact test p = 0.0315) (Table 2).
Regarding the overall incidence of organ-specific auto-
immunity in our patients (28 out of 66, 42.4%), by ad-
ding one patient with anti-transglutaminase Abs [age
9.1, karyotype 46,del(X)(p11)] and the patient with islet-
related Abs (age 16.2, karyotype 45,X), again no statisti-
cally significant difference was observed within the dif-
ferent age groups (χ2 Test, p > 0.05).
Interestingly, among patients affected by Hashimoto’s
thyroiditis with clinical or subclinical hypothyroidism, 3
out of 14 patients developed clinical disease and are cur-
rently under substitutive treatment with levothyroxine
(LT4) (Table 3).
Discussion
An increased incidence of autoimmunity has been large-
ly documented in TS [3,7] (Table 4). In particular, an
increased frequency of thyroid abnormalities has been
reported; in addition, in several studies this frequency
varied greatly. This wide range of results could be due to
selection bias, inclusion of pediatric versus adult patients
and karyotype differences. Generally, thyroid Abs can be
detected in a percentage of patients that varies between
3.9 and 87.5%, while for thyroid dysfunction the percen-
tage varies between 4.3 and 40% [26-29] as assessed by
clinical and laboratory parameters; in the majority of
studies the incidence of thyroid autoimmune disorders
exceeded 20% [7,9,17,18,30,31].
By analysing a group of 66 TS patients, including chil-
dren, adolescents and young adults up to the age of
29.9 years, we observed an overall increased incidence
of organ-specific autoimmunity. We need to point out
that the main limitation of our study is its retrospective
character and the limited number of patients included.







within the karyotype group(*)
Percentage of patients
with thyroid autoimmunity
within the karyotype group
Percentage of patients with
thyroid autoimmunity in respect
to the total group of patients
45,X 31 14 45.2% 21.2%
Mosaicism and others 29 7 24.1% 10.6%
X isochromosome 6 5(**) 83.3% 7.6%
Autoimmunity prevalence is calculated over the total number of patients per karyotype and over the total 66 TS patients in each karyotype group(*). There was a
statistically significant difference in the frequency of thyroid autoimmunity within the different karyotype groups (χ2-test p = 0.0173). When comparing the X
isochromosome group with the pooled group of other karyotypes, of note, the frequency of thyroid autoimmunity was statistically higher in this group(**).
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vant studies that were published in the field within the
past twenty years and include similar numbers of patients
(Table 4).
The observed incidence of thyroid autoimmunity in
our study was 39.4%; 21.2% of patients were affected by
clinical Hashimoto’s thyroiditis and 18.2% by preclinical
autoimmune thyroiditis. This latter is characterised by
the presence of circulating thyroid autoantibodies, nor-
mal thyroid hormone levels and/or echographic pattern
of diffuse hypoechogenicity. These data clearly confirm
an increased incidence of thyroid autoimmunity in TS
patients from the estimated incidence of 4.9% of females
in the Italian population as assessed by high antibody
titer and hypoechogenic ultrasound in the Pescopagano
survey [32-34]. There was no statistically significant dif-
ference in the frequency of autoimmunity among the
different age groups.
In comparison with other relevant investigations, in a
study by Chiovato et al. [12], conducted on 75 Italian TS
patients, thyroid abnormalities and thyroid Abs occurredTable 3 Characteristics of TS patients affected by Hashimoto’
Patient Age (years)
PF 9.4 45,X
FG 10.3 mos 45,X[6]/46,X,i(X)(
MF 14.4 45,X
BI 15.4 mos 45,X[93]/46,X,i(X
DF 16.3 46,X,del(X)(p22)
BF 16.4 mos 45,X,der(2)t(2;10
DE 18.3 mos 45,X[68]/46,XX[3
IA 18.5 mos 45,X[26],46,XX[7
SI 20.3 45,X
LL 27.6 45,X
SS 27.8 mos 45,X[44]/46,X,r(X
PV 13.2 mos 45,X[25]/46,X,r(X
FS 17.1 mos 45,X[94]/46,XX[6
TM 25.7 mos 45,X[40]/46,X,i(X
HT = Hashimoto’s thyroiditis; H = hypothyroidism; SH = subclinical hypothyroidism.
The case report related to patient BF was published in Reference [1].
Table refers to the age, karyotype and presence of clinical or subclinical hypothyroiin 20% and in 40% of individuals respectively. The fre-
quency of thyroid Abs increased with age from 15% in
patients younger than 10 years to 30% in patients older
than 20 years. The prevalence of autoimmune disease in-
creased significantly after the age of 13 years, to reach
its peak in the third decade of life [12].
Similarly in a recent report on the Polish TS popula-
tion by Gawlik et al. [35], 31% of TS patients had circu-
lating thyroid Abs at the median age of 14.1 years, while
17% of patients developed hypothyroidism as a conse-
quence of Hashimoto’s thyroiditis. Autoantibodies ap-
peared mainly after the age of 13 years, but from the
beginning of the observation to the end of the follow-up,
this frequency increased from 25.5 to 50%.
In a Japanese study by Fukuda et al. [36], 65 TS wo-
men (age 30 ± 9 years old, range 15–61) were retrospec-
tively evaluated: more than half of adults had thyroid
autoantibodies (57%). Again, the study found an age-
related increase of thyroid Abs. The prevalence was 7%
below 30 years of age and 14% above 30 years. An inves-
















dism in TS patients affected by Hashimoto’s thyroiditis.
Table 4 The epidemiology of autoimmune thyroid disease in Turner syndrome






% of subjects with
thyroid autoimmune
disease
% of subjects with
thyroid autoimmune
disease in IsoXq






Bright et al. 1982 [26] 24 15 ± 5 Thyroiditis USA 87.5 100 na na
Germain et al. 1986 [23] 100 15 weeks- 19 years Thyroiditis USA 50 57 22 0
Gluck et al. 1992 [27] 77 5-14 Thyroiditis Germany 3.9 na na na
de Kerdanet et al. 1994 [21] 67 5.5-34 Thyroiditis France 26.9 68.8 23.9 na
Radetti et al. 1995 [30] 478 3.6-25.3 Thyroiditis Italy 22.2 na 6.1 0.6
Chiovato et al. 1996 [12] 75 3-30 Thyroiditis Italy 13.3 40 10.6 1.3
Medeiros et al. 2000 [13] 71 0-20 Thyroiditis Brazil 23.9 na 15.5 0
Medeiros et al. 2009 [14] 17/80 (follow-up) 5.9-22.6 Thyroiditis Brazil 59 33 82.4 5.8
Elsheikh et al. 2001 [18] 145 16-52 Thyroiditis UK 41 83 15 0.7
El-Mansouri et al. 2005 [31] 91 25-65 Thyroiditis Sweden 27.5 27.8 25 2
Livadas et al. 2005 [17] 84 0-19 Thyroiditis Greece 60.7 71 24 21 with Abs 2.5
Bettendorf et al. 2006 [15] 120/327 (follow-up) >16 Presence of thyroid
and celiac disease Abs
Germany 36 5.8 57.1 0
Mc Carthy et al. 2008 [3] 100 7-17 Thyroiditis USA 51 na na na
Fukuda et al. 2009 [36] 65 15-61 Thyroiditis Japan 57 na 31 4.6
Mortensen et al. 2009 [28] 107 6-60 Thyroiditis, celiac disease Denmark 45 39 15 1.9
Dias et al . 2010 [4] 56 0.8-52 Celiac disease Brazil na na na na
Jөrgensen et al. 2010 [7] 798 na Female predominant Denmark 1.6 12.5 with na 0.6
Hashimoto’s







Gawlik et al. 2011 [35] 86 0-17.4 Thyroiditis, celiac disease, T1D,
alopecia
Poland 36 with Abs 17.4 with
Hashimoto’s thyroiditis


















Table 4 The epidemiology of autoimmune thyroid disease in Turner syndrome (Continued)
Bakalov et al. 2012 [10] 224 18-67 High prevalence of Hashimoto’s
thyroiditis, inflammatory bowel
disease and celiac disease
USA 37 58.3 na 0
Hamza et al. 2012 [20] 80 4.7-22.3 Thyroiditis Egypt 35 anti-TPO 15 anti-Tg 57.9 anti-TPO 26.3
anti-Tg
6.3 1.3
Kucharska et al. 2013 [29] 54 11.9 ± 2.5 Thyroiditis Poland 64.8 anti-TPO 24 anti-Tg
14.8 anti-NIS
na 20 0
N = number; na = not available; NIS = natrium/iodide symporter.
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tive for one or more Abs.
It is generally recognised that autoimmune thyroi-
ditis has etiopathogenetic mechanisms that are similar
to those of Graves’ disease. In keeping with previous stud-
ies [12,17,20], no cases of Graves’ disease were observed
in our investigation. By contrast, Graves’ disease was ob-
served in 2 out of 84 TS patients (2.5%) versus 0.5-1% in
the general population in a study by Livadas et al. [17]. In
the same study by Fukuda et al. mentioned above [36], out
of 65 TS women, 3 had Graves’ disease and 31% was
hypothyroid. Similarly, only one Graves’ disease patient
was reported by Chiovato et al. [12] out of 75 TS patients
investigated.
Although statistical significance was not achieved, ac-
cording to several studies, the overall frequency of thy-
roid autoimmunity was higher in TS patients with X
isochromosome i(X)(p10) karyotype [12,17-20].
In keeping with previous studies, in our investigation
the group with X isochromosome had a number of pa-
tients affected by thyroid autoimmunity higher than in
the other karyotype groups. It is noteworthy that in the
investigation by Chiovato et al. [12], the only patient
with Graves’ disease had the X isochromosome karyo-
type. In the study by Livadas et al. [17], 71% of patients
with IsoXq had positive Abs and over 41 to 47% pre-
sented the other karyotipic abnormalities. In a study by
Hamza et al. [20], there was no statistically significant
association between karyotype 45,X and the overall
prevalence of Abs. On the contrary, a significant as-
sociation was confirmed between IsoXq and the in-
creased prevalence of anti-TPO, anti-Tg Abs and GADA,
whereas, this karyotype was not associated with anti-
transglutaminase Abs.
We observed thyroid autoimmunity in one patient
under 8 years of age (6.9 years old). Thus we recom-
mend that thyroid evaluation and testing of related Abs
in girls with TS should be carried out even before the
age of 8 years. Some studies report evidence that there is
no incidence of thyroid Abs and/or hypothyroidism be-
fore the age of 8 years [9,17,31]. In the study by Livadas
et al. [17], thyroid dysfunction occurred more frequently
in girls with TS, and especially with i(X)(q10). Thyroid
dysfunction was manifested early, at the age of 8 years.
In other studies, hypothyroidism was detected in girls
before the age of 10 years, while de Kerdanet et al. [21],
detected the disease in patients older than 10 years.
Finally, we observed that in our cohort of TS patients,
the high incidence of autoimmune diseases that are nor-
mally characterised by male preponderance as observed
in the Danish TS registry [7], was not present in our co-
hort of TS patients. In addition, one patient developed
CD at the age of 3.5 years [1] and another presented anti-
transglutaminase Abs at the age of 9.3 years. Although thispositivity for CD screening (3%) is lower than that re-
ported in other studies [10,34], its screening should be
part of the routine follow up of girls affected by TS since
the first years of life.
Conclusions
Our data confirm a high frequency of thyroid auto-
immunity in Italian Turner patients. Patients with X
isochromosome are more prone to develop thyroid auto-
immunity. Further, an early assay of autoantibodies and
monitoring thyroid hormones is fundamental for detec-
ting hypothyroidism precociously and start adequate re-
placement therapy.
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